176 related articles for article (PubMed ID: 20538338)
1. Folylpolyglutamate synthetase gene transcription is regulated by a multiprotein complex that binds the TEL-AML1 fusion in acute lymphoblastic leukemia.
Leclerc GJ; Sanderson C; Hunger S; Devidas M; Barredo JC
Leuk Res; 2010 Dec; 34(12):1601-9. PubMed ID: 20538338
[TBL] [Abstract][Full Text] [Related]
2. Old drug--new insights--better treatment?
Diakos C; Kager L
Leuk Res; 2010 Dec; 34(12):1558-9. PubMed ID: 20594594
[No Abstract] [Full Text] [Related]
3. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors induce FPGS mRNA expression and intracellular accumulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy.
Leclerc GJ; Mou C; Leclerc GM; Mian AM; Barredo JC
Leukemia; 2010 Mar; 24(3):552-62. PubMed ID: 20072153
[TBL] [Abstract][Full Text] [Related]
5. Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia.
Sera Y; Yamasaki N; Oda H; Nagamachi A; Wolff L; Inukai T; Inaba T; Honda H
Cancer Sci; 2016 Jul; 107(7):890-8. PubMed ID: 27088431
[TBL] [Abstract][Full Text] [Related]
6. ETO, but not leukemogenic fusion protein AML1/ETO, augments RBP-Jkappa/SHARP-mediated repression of notch target genes.
Salat D; Liefke R; Wiedenmann J; Borggrefe T; Oswald F
Mol Cell Biol; 2008 May; 28(10):3502-12. PubMed ID: 18332109
[TBL] [Abstract][Full Text] [Related]
7. The TEL-AML1 fusion protein of acute lymphoblastic leukemia modulates IRF3 activity during early B-cell differentiation.
de Laurentiis A; Hiscott J; Alcalay M
Oncogene; 2015 Dec; 34(49):6018-28. PubMed ID: 25893288
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of TEL/AML1 fusion protein in the regulation of human CR1 gene promoter.
Song H; Kim JH; Rho JK; Park SY; Kim CG; Choe SY
Mol Cells; 1999 Oct; 9(5):560-3. PubMed ID: 10597047
[TBL] [Abstract][Full Text] [Related]
9. Expression of Tel-Aml1 transcript variants in pediatric acute lymphoblastic leukemia.
Kustanovich AM; Belevtsev MV; Stasevich IV; Savitskaya TV; Jutzkevich RI; Savva NN; Aleinikova OV
Leukemia; 2006 Jan; 20(1):165-7. PubMed ID: 16307024
[No Abstract] [Full Text] [Related]
10. Predicting interactome network perturbations in human cancer: application to gene fusions in acute lymphoblastic leukemia.
Hajingabo LJ; Daakour S; Martin M; Grausenburger R; Panzer-Grümayer R; Dequiedt F; Simonis N; Twizere JC
Mol Biol Cell; 2014 Dec; 25(24):3973-85. PubMed ID: 25273558
[TBL] [Abstract][Full Text] [Related]
11. Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesis.
Zaza G; Yang W; Kager L; Cheok M; Downing J; Pui CH; Cheng C; Relling MV; Evans WE
Blood; 2004 Sep; 104(5):1435-41. PubMed ID: 15142881
[TBL] [Abstract][Full Text] [Related]
12. [Detection of fusion genes resulting from chromosome abnormalities in childhood acute lymphoblastic leukemia].
He J; Chen ZX; Xue YQ; Li JQ; He HL; Huang YP; He YX; Chai YH; Zhu LL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):551-3. PubMed ID: 16215946
[TBL] [Abstract][Full Text] [Related]
13. GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia.
Holmlund T; Lindberg MJ; Grander D; Wallberg AE
Leukemia; 2013 Mar; 27(3):578-85. PubMed ID: 23044487
[TBL] [Abstract][Full Text] [Related]
14. Expression differences in TEL-AML1 fusion gene in leukemia glucocorticoid-sensitive and -resistant cell lines.
Wang XW; Xu YH
Genet Mol Res; 2015 Jul; 14(3):7883-93. PubMed ID: 26214469
[TBL] [Abstract][Full Text] [Related]
15. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
[TBL] [Abstract][Full Text] [Related]
16. TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.
Lin PC; Chang TT; Lin SR; Chiou SS; Jang RC; Sheen JM
Kaohsiung J Med Sci; 2008 Jun; 24(6):289-96. PubMed ID: 18635414
[TBL] [Abstract][Full Text] [Related]
17. [Classical and molecular cytogenetic abnormalities in 124 pediatric patients with acute lymphoblastic leukemia].
Chai YH; Lü H; Li JQ; Lu J; Xiao PF; He YX; Shao XJ
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):684-6. PubMed ID: 18021563
[TBL] [Abstract][Full Text] [Related]
18. Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein.
Guidez F; Petrie K; Ford AM; Lu H; Bennett CA; MacGregor A; Hannemann J; Ito Y; Ghysdael J; Greaves M; Wiedemann LM; Zelent A
Blood; 2000 Oct; 96(7):2557-61. PubMed ID: 11001911
[TBL] [Abstract][Full Text] [Related]
19. TEL/AML1 overcomes drug resistance through transcriptional repression of multidrug resistance-1 gene expression.
Asakura K; Uchida H; Miyachi H; Kobayashi H; Miyakawa Y; Nimer SD; Takahashi H; Ikeda Y; Kizaki M
Mol Cancer Res; 2004 Jun; 2(6):339-47. PubMed ID: 15235109
[TBL] [Abstract][Full Text] [Related]
20. Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics.
Kager L; Cheok M; Yang W; Zaza G; Cheng Q; Panetta JC; Pui CH; Downing JR; Relling MV; Evans WE
J Clin Invest; 2005 Jan; 115(1):110-7. PubMed ID: 15630450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
